|
Volumn 55, Issue 4, 2009, Pages 331-340
|
Pharmacoeconomy of diabetes mellitus - trends in the Czech Republic;Farmakoekonomika Iéčby diabetu - Trendy u nás
|
Author keywords
Consumption of medical services; Diabetes mellitus; Medical insurance; Pharmacoeconomy
|
Indexed keywords
ANTIDIABETIC AGENT;
GLIBENCLAMIDE;
GLIMEPIRIDE;
GLIPIZIDE;
GLIQUIDONE;
INSULIN;
INSULIN ASPART;
INSULIN GLARGINE;
INSULIN LISPRO;
ISOPHANE INSULIN;
METFORMIN;
NEUTRAL INSULIN;
PIOGLITAZONE;
ROSIGLITAZONE;
CONFERENCE PAPER;
CZECH REPUBLIC;
DIABETES MELLITUS;
DISEASE PREDISPOSITION;
HEALTH CARE COST;
HEALTH CARE ORGANIZATION;
HEALTH CARE QUALITY;
HEALTH INSURANCE;
HEALTH SERVICE;
HUMAN;
INCIDENCE;
LIFESTYLE MODIFICATION;
MEDICAL DECISION MAKING;
MEDICAL SPECIALIST;
OUTPATIENT DEPARTMENT;
ARTICLE;
COST CONTROL;
DRUG COST;
ECONOMICS;
MEDICINE;
PHYSICIAN;
STATISTICS;
COST CONTROL;
CZECH REPUBLIC;
DIABETES MELLITUS;
DRUG COSTS;
HEALTH CARE COSTS;
HUMANS;
HYPOGLYCEMIC AGENTS;
PHYSICIANS;
SPECIALTIES, MEDICAL;
|
EID: 66349129308
PISSN: 0042773X
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (5)
|
References (4)
|